ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "IASLC - EGFR Mutant NSCLC Post Osimertinib"
Episode Synopsis
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a new Virtual Tumor Board on EGFR mutant NSCLC and acquired resistance. Dr. Liu is joined by two thoracic medical oncologists who are both global experts in targeted therapy.
More episodes of the podcast Lung Cancer Considered
LCC in Hungarian: WCLC 2025 Highlights
31/10/2025
LCC in Greek: WCLC 2025 Highlights
10/10/2025
LCC in Arabic: WCLC 2025 Highlights
03/10/2025
Lung Cancer Considered: Targeting EGFR NSCLC
03/10/2025
In God we trust